Background and Objective. To mitigate the spread of the virus responsible for COVID-19, known as SARS-CoV-2, there is an urgent need for massive population testing. Due to the constant shortage of PCR (polymerase chain reaction) test reagents, which are the tests for COVID-19 by excellence, several medical centers have opted for immunological tests to look for the presence of antibodies produced against this virus. However, these tests have a high rate of false positives (positive but actually negative test results) and false negatives (negative but actually positive test results) and are therefore not always reliable. In this paper, we proposed a solution based on Data Analysis and Machine Learning to detect COVID-19 infections. Methods. Our analysis and machine learning algorithm is based on most cited two clinical datasets from the literature: one from San Raffaele Hospital Milan Italia and the other from Hospital Israelita Albert Einstein São Paulo Brasilia. The datasets were processed to select the best features that most influence the target, and it turned out that almost all of them are blood parameters. EDA (Exploratory Data Analysis) methods were applied to the datasets, and a comparative study of supervised machine learning models was done, after which the support vector machine (SVM) was selected as the one with the best performance. Results. SVM being the best performant is used as our proposed supervised machine learning algorithm. An accuracy of 99.29%, sensitivity of 92.79%, and specificity of 100% were obtained with the dataset from Kaggle (https://www.kaggle.com/einsteindata4u/covid19) after applying optimization to SVM. The same procedure and work were performed with the dataset taken from San Raffaele Hospital (https://zenodo.org/record/3886927#.YIluB5AzbMV). Once more, the SVM presented the best performance among other machine learning algorithms, and 92.86%, 93.55%, and 90.91% for accuracy, sensitivity, and specificity, respectively, were obtained. Conclusion. The obtained results, when compared with others from the literature based on these same datasets, are superior, leading us to conclude that our proposed solution is reliable for the COVID-19 diagnosis.
Deep learning and machine learning provide more consistent tools and powerful functions for recognition, classification, reconstruction, noise reduction, quantification and segmentation in biomedical image analysis. Some breakthroughs. Recently, some applications of deep learning and machine learning for low-dose optimization in computed tomography have been developed. Due to reconstruction and processing technology, it has become crucial to develop architectures and/or methods based on deep learning algorithms to minimize radiation during computed tomography scan inspections. This chapter is an extension work done by Alla et al. in 2020 and explain that work very well. This chapter introduces the deep learning for computed tomography scan low-dose optimization, shows examples described in the literature, briefly discusses new methods for computed tomography scan image processing, and provides conclusions. We propose a pipeline for low-dose computed tomography scan image reconstruction based on the literature. Our proposed pipeline relies on deep learning and big data technology using Spark Framework. We will discuss with the pipeline proposed in the literature to finally derive the efficiency and importance of our pipeline. A big data architecture using computed tomography images for low-dose optimization is proposed. The proposed architecture relies on deep learning and allows us to develop effective and appropriate methods to process dose optimization with computed tomography scan images. The real realization of the image denoising pipeline shows us that we can reduce the radiation dose and use the pipeline we recommend to improve the quality of the captured image.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.